Financing round Cellpoint
We advised Cellpoint on its financing round, in which it raised growth capital from NanoDimension. CellPoint is active in the field of immuno-oncology and is developing a disruptive CAR-T production and supply model that allows cancer patients to be treated faster, more effectively and at lower cost.
Niels Hofkes5 August 2020
